SLC2A1 and breast cancer: As is shown in the figure, 10 out of 53 analyses (4 out of 14 datasets) revealed SLC2A1 upregulation in breast cancer, while 1 out of 53 analyses (1 out of 14 datasets) displayed SLC2A1 downregulation.